Dr. Amro Elshoury

Amro Elshoury


Specializing In:

Polycythemia Vera (PV) Myelofibrosis (MF) Mastocytosis Eosinophilia Chronic myeloid leukemia (CML) Myelodysplastic syndrome (MDS) Acute leukemia (AML and ALL) Essential thrombocythemia



Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Leukemia Service
  • Department of Medicine


Education and Training:

  • 2011 - M.Sc. - Masters of Science in Hematology
  • 2009 - MD - Ain Shams University School of Medicine (M.B.B.Ch) Cairo, Egypt


  • 2013 - Internal Medicine Residency, Albany Medical Center, Albany, NY


  • 2012 - Research fellowship at Keck School of Medicine, University of Southern California, Los Angeles, CA
  • 2019 - Hematology and Medical Oncology Fellowship, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Board Certification:

  • American Board Of Internal Medicine

Professional Memberships:

  • American Society of Hematology
  • American Society for Blood and Marrow Transplantation
  • American Society of Clinical Oncology
  • The Egyptian Medical Syndicate

Honors & Awards

  • 2018 - University at Buffalo (UB) Gerald L. Logue Award for outstanding medical trainee in hematology and oncology at Roswell Park
  • 2017 - Thomas F. Frawley, MD, Residency Research Fellowship Award – UB annual award for the outstanding medical trainee’s research
  • 2019 - Ain Shams University Top Academic Honors



1- Elshoury A, Przespolewski A, Baron J, Wang ES. Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors. Expert Rev Anticancer Ther. 2019 Mar;19(3):273-286

2-Elshoury Amro, Wallace PK, Borowitz MJ, Kader A, Choi C, Ho C, Balderman S, Ross M, Hahn T, O'Neill V, McCarthy PL, Chen GL. BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia. Bone Marrow Transplant. 2018 ;53(5):651-653

3-Elshoury A, Baron J, Przespolewski A, Wang E. Optimizing FLT3 Inhibitor Monotherapy in Acute Myeloid Leukemia. The journal of targeted therapies in cancer. 2017 December.

4- Przespolewski A, Szeles, Elshoury A, Wang E. Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia. Targeted oncology. 2017 October 25

5- Abdel-Azim H, Elshoury A, Mahadeo KM, Parkman R, Kapoor N. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution. Biol Blood Marrow Transplant. 2017 Sep;23(9):1437-1446.

Request an Appointment

Make an appointment by calling 1-800-ROSWELL (1-800-767-9355)

Make an Appointment